SignatureFD’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.82K Sell
452
-25
-5% -$437 ﹤0.01% 2774
2026
Q1
$9.14K Buy
477
+130
+37% +$2.83K ﹤0.01% 2558
2025
Q4
$7.63K Buy
347
+115
+50% +$2.08K ﹤0.01% 2540
2025
Q3
$2.82K Sell
232
-539
-70% -$7.3K ﹤0.01% 2855
2025
Q2
$14.4K Sell
771
-927
-55% -$18.4K ﹤0.01% 2192
2025
Q1
$32.5K Sell
1,698
-567
-25% -$16.6K ﹤0.01% 1807
2024
Q4
$81.6K Buy
2,265
+51
+2% +$1.73K ﹤0.01% 1338
2024
Q3
$93.9K Sell
2,214
-93
-4% -$3.94K ﹤0.01% 1244
2024
Q2
$92.9K Buy
2,307
+522
+29% +$21.8K ﹤0.01% 1200
2024
Q1
$63.2K Buy
1,785
+94
+6% +$2.52K ﹤0.01% 1421
2023
Q4
$50K Buy
1,691
+1,517
+872% +$31.5K ﹤0.01% 1461
2023
Q3
$3.61K Buy
174
+58
+50% +$1.59K ﹤0.01% 2603
2023
Q2
$2.85K Sell
116
-2
-2% -$64 ﹤0.01% 2695
2023
Q1
$4.79K Sell
118
-448
-79% -$18.5K ﹤0.01% 2521
2022
Q4
$25.4K Sell
566
-54
-9% -$2.44K ﹤0.01% 1684
2022
Q3
$30K Buy
620
+319
+106% +$17.5K ﹤0.01% 1555
2022
Q2
$18K Buy
301
+242
+410% +$19.9K ﹤0.01% 1841
2022
Q1
$7K Buy
59
+45
+321% +$5.25K ﹤0.01% 2366
2021
Q4
$2K Buy
+14
New +$1.89K ﹤0.01% 2801
2021
Q3
Sell
-1
Closed 3210
2021
Q2
$0 Buy
+1
New +$89 ﹤0.01% 3062
2021
Q1
Sell
-1
Closed 2829
2020
Q4
$0 Hold
1
﹤0.01% 2704
2020
Q3
$0 Hold
1
﹤0.01% 2759
2020
Q2
$0 Hold
1
﹤0.01% 2667
2020
Q1
$0 Hold
1
﹤0.01% 2447
2019
Q4
$0 Hold
1
﹤0.01% 2269
2019
Q3
$0 Hold
1
﹤0.01% 2202
2019
Q2
$0 Hold
1
﹤0.01% 2159
2019
Q1
$0 Buy
+1
New +$53 ﹤0.01% 2058

Other funds holding TNDM

SignatureFD's TNDM Position: Q2 2026 in Review

SignatureFD reduced its Tandem Diabetes Care (TNDM) stake by 5.2% in Q2 2026, selling an estimated $437 and leaving 452 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

SignatureFD first reported a position in TNDM in Q1 2019 and has held it in 28 quarters since. The position peaked at $93.9K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • SignatureFD held 452 shares of Tandem Diabetes Care worth $6.82K as of Q2 2026.
  • SignatureFD sold 25 Tandem Diabetes Care shares in Q2 2026, an estimated $437.
  • Tandem Diabetes Care made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2774 holding.
  • SignatureFD first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 28 quarters since.
  • SignatureFD's Tandem Diabetes Care position peaked at $93.9K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.